Ground every answer in facts on this page and the original listing. We never invent Glassdoor-style reviews or salaries that are not in our data.
Strong fit if you have senior market access/pricing leadership in specialty or neurology biopharma and can own global Alzheimer’s value & access strategy on-site in the Cambridge, MA biotech hub. Thin public salary and culture data here—validate total rewards and team scope directly with Biogen.
As Senior Director, Global Pricing and Access (V&A) for Alzheimer’s disease, you would lead pricing, reimbursement, and access strategy for Biogen’s AD franchise across markets: evidence packages for payers, value narratives, launch and lifecycle pricing, and cross-functional work with HEOR, medical, commercial, and policy. Expect external payer engagement, internal governance on list/net strategy, and readiness for evolving AD access landscapes.
Build depth in global pricing architecture, HTA/payer evidence, Alzheimer’s disease epidemiology and care pathways, launch sequencing, and stakeholder influence. No certification list is provided for this posting; prioritize case-based access strategy and cross-market negotiation experience over generic credentials.
No. The listing marks remote as 0, so plan for on-site presence in the Cambridge area associated with Biogen’s Massachusetts base.
Pricing, reimbursement, and access strategy so products can reach patients under payer and HTA constraints—especially relevant for Alzheimer’s therapies.
See the company overview on Wikipedia and news via company and market coverage (e.g., pipeline and stock developments).
Website: biogen.com
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate (Tecfidera), diroximel fumarate (Vumerity), interferon beta-1a (AVONEX), peginterferon beta-1a (Plegridy), and natalizumab (Tysabri), all for the treatment of multiple sclerosis ; nusinersen (Spinraza) for the treatment of spinal muscular atrophy ; omaveloxolone (Skyclarys) for the treatment of Friedreich's ataxia ; tofersen (Qalsody) for the treatment of A…
Public cache only — not an employee review.
Biogen seeks a Full Time Senior Director, Global Pricing and Access (V&A) for Alzheimer's Disease in Cambridge, Middlesex County. Lead strategic initiatives in global pricing and market access for our Alzheimer's disease portfolio, shaping patient access and commercial success for innovative therapies. About the Role In this senior leadership position, you'll oversee the development and execution of comprehensive pricing and market access strategies supporting Biogen's Alzheimer's disease pipeline from development through global launch and beyond. You'll partner across clinical, medical, commercial, and regulatory functions to align value evidence with business objectives and ensure patients worldwide can access our therapies. What You'll Do Develop and execute global pricing strategies that reflect market dynamics, regulatory requirements, and patient access needs Lead market access and reimbursement initiatives to secure favorable positioning with payers and health systems Partner with development and medical teams to build health economics evidence that demonstrates clinical and economic value Direct relationships with key payers, health authorities, and government organizations across major markets Build and lead a team of pricing and market access specialists Analyze competitive intelligence and market trends to inform pricing and access strategy Align pricing and access strategy with product development timelines and commercial launch plans What We're Looking For 15+ years of pharmaceutical industry experience in pricing, market access, health economics, or commercial leadership Demonstrated success building and executing global pricing strategies for specialty or innovative therapies Deep knowledge of Alzheimer's disease, CNS markets, and reimbursement landscapes in major geographies Experience managing complex pricing and access regulations across international markets Excellent strategic planning, stakeholder management, and cross-functional leadership capabilities MBA or advanced degree in health economics, health policy, or related field preferred About Biogen Biogen is a global biotechnology company pioneering medicines for neurodegenerative diseases, immunology, and serious health conditions. Based in Cambridge, Biogen combines cutting-edge science with a commitment to improving outcomes for patients worldwide. How to Apply To apply for this Senior Director, Global Pricing and Access (V&A) Alzheimer's Disease position at Biogen in Cambridge, Middlesex County, submit your application through this listing.
Generated for personal interview prep · 2026-07-19 UTC · getajob.ai